Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity? (Q36752124)

16 August 2017

1 reference

title

Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity? (English)

1 reference

16 August 2017

Sylvia Heeneman

1

1 reference

16 August 2017

Marjo M P C Donners

series ordinal

2

1 reference

16 August 2017

Lili Bai

series ordinal

3

1 reference

16 August 2017

Mat J A P Daemen

series ordinal

4

1 reference

16 August 2017

1 March 2007

1 reference

Expert Review of Cardiovascular Therapy

16 August 2017

1 reference

16 August 2017

5

1 reference

16 August 2017

2

1 reference

16 August 2017

345-364

1 reference

Immunomodulation to combat atherosclerosis: the potential role of immune regulatory cells

16 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells. Effects of mechanical strain on monocyte adhesion to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Transcriptional inhibition by interleukin-6 of the class A macrophage scavenger receptor in macrophages derived from human peripheral monocytes and the THP-1 monocytic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Localized interleukin-10 gene transfer induces apoptosis of alloreactive T cells via FAS/FASL pathway, improves function, and prolongs survival of cardiac allograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Tissue factor regulation in vascular smooth muscle: a summary of studies performed using in vivo and in vitro models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Vascular inflammation and the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Acquisition of lymphokine-producing phenotype by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Low-dose aspirin for the prevention of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Lack of significant effect of low doses of aspirin on the concentrations of C-reactive protein in a group of individuals with atherothrombotic risk factors and vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Review of major clinical trials with mycophenolate mofetil in cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Effect of mycophenolate mofetil on atherosclerosis in a rabbit model: initial histologic and immunohistochemical analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Rapamycin: an anti-cancer immunosuppressant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

21 January 2018

Coronary-artery stents

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Oral rapamycin inhibits growth of atherosclerotic plaque in apoE knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Effects of rapamycin on the arterial inflammatory response in atherosclerotic plaques in Apo-E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Protective Effect of the Immunosuppressant Sirolimus Against Aortic Atherosclerosis In Apo E-Deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Effect of sirolimus on the cholesterol content of aortic arch in ApoE knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Oral everolimus inhibits in-stent neointimal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

NFAT: ubiquitous regulator of cell differentiation and adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Cardiovascular toxicities of immunosuppressive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Low-dose FK506 blocks collar-induced atherosclerotic plaque development and stabilizes plaques in ApoE-/- mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Finding vulnerable atherosclerotic plaques: is it worth the effort?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Widespread coronary inflammation in unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: long-term follow-up with intravascular ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

Diffuse and Active Inflammation Occurs in Both Vulnerable and Stable Plaques of the Entire Coronary Tree

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.2.345

21 January 2018

Identifiers

DOI

10.1586/14779072.5.2.345

1 reference

16 August 2017

1 reference